Yiming Liu

Partner in Charge – Shanghai
Full contact info

Experience

Akeso Completes HK$1.9 Billion Follow-On Public Offering

October 22, 2024

Cooley advised Akeso (Hong Kong Stock Exchange code: 9926.HK), a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing and commercializing innovative medicines that address global medical needs, on its HK$1.9 billion (approximately US$250 million) follow-on public offering.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Ying Liu
Associate, Hong Kong
April Wang
Associate, Hong Kong

Related Practices & Industries

Zhejiang Taimei Medical Technology Announces HK$335.1 Million IPO

October 8, 2024

Cooley advised the underwriters of Zhejiang Taimei Medical Technology (Taimei), a digital solution provider focused on the pharmaceutical and medical device industry in China, on its HK$335.1 million initial public offering.

Related contacts

Ethan Jin
Partner, Beijing
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Lisa Yuan
Special Counsel, Beijing
Yiying Wang
Associate, Shanghai
Mengchao Wu
Associate, Beijing
Shuaiwen Wang
International Legal Project Manager, Beijing
Alex Wu
International Legal Project Manager, Shanghai
Xander Lee
Partner, Santa Monica
Alessandra Murata
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Megan Drill
Associate, San Diego
Rick Jantz
Associate, Santa Monica

Related Practices & Industries

FutureGen Announces License Agreement With AbbVie

June 13, 2024

Cooley advised FutureGen Biopharmaceutical, an innovative biopharmaceutical company committed to providing high-quality innovative biologics for patients with cancer, immune diseases and other diseases, on its license agreement with AbbVie to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Xiaoyu Xu
Associate, Beijing
Aaron Pomeroy
Partner, Colorado
Geoffrey Spolyar
Partner, Boston
David Burns
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Zhijing Yu
Associate, Singapore

Related Practices & Industries

D3 Bio Completes $62 Million Series A+

April 15, 2024

Cooley advised D3 Bio – an emerging global biotechnology company that focuses on discovery, development and registration of innovative cancer drugs – on the close of its $62 million Series A+ financing.

Read more

Related contacts

Christina Zhang
Partner, Shanghai
Andrew Harline
Partner in Charge – Singapore, Singapore
Lunga Su
Associate, Shanghai
Xander Lee
Partner, Santa Monica
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Zack Gong
Associate, Shanghai
Qi Wang
Associate, Beijing
Kaiting Yang
Associate, Hong Kong
Cindy Pan
International Legal Project Manager, Hong Kong

Related Practices & Industries

Brii Biosciences Announces Agreements to Acquire VBI Vaccines’ IP Rights in BRII-179

February 14, 2024

Cooley advised Brii Biosciences on its agreements with VBI Vaccines (NASDAQ: VBIV) to ensure expansion and control of future clinical and commercial supplies of BRII-179, a late-stage clinical asset in Brii Bio’s hepatitis B virus functional cure portfolio. With operations in major biotechnology centers in the US and China, Brii Bio (HKSE: 2137) is a Hong Kong Stock Exchange-listed biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Rama Padmanabhan
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
Jason Savich
Partner, San Francisco
Lila Hope
Partner, Palo Alto
Michael Klein
Partner, New York
Michelle Garcia Schulman
Partner, Reston
Matthew S. Scarano
Associate, San Diego
Jameson Davis
Associate, Boston
Kaiting Yang
Associate, Hong Kong
Ross Eberly
Partner, Santa Monica
Jeffrey J. Tolin
Partner, New York
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Robert Eisenbach
Of Counsel, San Francisco
Rena Kaminsky
Special Counsel, Palo Alto
Olya Antle
Associate, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Yoni Horn
Associate, Santa Monica
Lunga Su
Associate, Shanghai
Yiying Wang
Associate, Shanghai

Related Practices & Industries

View more

Admissions and credentials

New York

Hong Kong (Registered Foreign Lawyer)

Rankings and accolades

China Business Law Journal (CBLJ) “The A-List” elite lawyers in China - Growth Driver (2023-2024)

IFLR1000 Asia Pacific Rankings - Highly Regarded Lawyer: Capital Markets, M&A and Private Equity practices in China (Foreign Firm) (2024)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Capital Markets Lawyers (2022)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Rising Lawyers (2022)